Ocugen (OCGN) Cash from Investing Activities Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.98% |
| Dec 31, 2025 | 32.57% |
| Sep 30, 2025 | -31.35% |
| Jun 30, 2025 | -45.99% |
| Mar 31, 2025 | -13.99% |
| Dec 31, 2024 | 9.03% |
| Sep 30, 2024 | 25.47% |
| Jun 30, 2024 | -33.39% |
| Mar 31, 2024 | -194.70% |
| Sep 30, 2023 | -31.39% |
| Jun 30, 2023 | 42.47% |
| Mar 31, 2023 | 63.53% |
| Dec 31, 2022 | -86.35% |
| Sep 30, 2022 | -15.03% |
| Jun 30, 2022 | -104.71% |
| Mar 31, 2022 | 51.18% |
| Dec 31, 2021 | -129.74% |
| Sep 30, 2021 | -159.05% |
| Jun 30, 2021 | -29.14% |
| Mar 31, 2021 | -52.16% |
| Dec 31, 2020 | -13.89% |
| Sep 30, 2020 | 46.42% |
| Jun 30, 2020 | 15.40% |
| Mar 31, 2020 | 43.43% |
| Dec 31, 2019 | 58.73% |
| Sep 30, 2019 | -9.75% |
| Jun 30, 2019 | -10.72% |
| Mar 31, 2019 | 38.47% |